| 1 | direct ownership by 1 | | | | | | | 5 | 0.16% |
| 2 | increasing direct ownership by | | | | | | | 5 | 0.16% |
| 3 | aug 09 2024 globe | | | | | | | 4 | 0.13% |
| 4 | no diagnostic substances health | | | | | | | 4 | 0.13% |
| 5 | diagnostic substances health care | | | | | | | 4 | 0.13% |
| 6 | products no diagnostic substances | | | | | | | 4 | 0.13% |
| 7 | live in this feed | | | | | | | 3 | 0.10% |
| 8 | software prepackaged software technology | | | | | | | 3 | 0.10% |
| 9 | computer software prepackaged software | | | | | | | 3 | 0.10% |
| 10 | in this feed see | | | | | | | 3 | 0.10% |
| 11 | this feed see more | | | | | | | 3 | 0.10% |
| 12 | the chart shows that | | | | | | | 3 | 0.10% |
| 13 | 2024 financial results and | | | | | | | 3 | 0.10% |
| 14 | biotechnology pharmaceutical preparations health | | | | | | | 3 | 0.10% |
| 15 | pharmaceutical preparations health care | | | | | | | 3 | 0.10% |
| 16 | units sec form 4 | | | | | | | 3 | 0.10% |
| 17 | inc submission status for | | | | | | | 3 | 0.10% |
| 18 | in the companys future | | | | | | | 2 | 0.07% |
| 19 | laboratory analytical instruments industrials | | | | | | | 2 | 0.07% |
| 20 | restoring power to customers | | | | | | | 2 | 0.07% |
| 21 | the companys future prospects | | | | | | | 2 | 0.07% |
| 22 | quarter 2024 financial results | | | | | | | 2 | 0.07% |
| 23 | new price target of | | | | | | | 2 | 0.07% |
| 24 | changed to approval on | | | | | | | 2 | 0.07% |
| 25 | sec form sc 13g | | | | | | | 2 | 0.07% |
| 26 | and lowers the price | | | | | | | 2 | 0.07% |
| 27 | results and provides business | | | | | | | 2 | 0.07% |
| 28 | outperform and lowers the | | | | | | | 2 | 0.07% |
| 29 | a outperform and lowers | | | | | | | 2 | 0.07% |
| 30 | with a outperform and | | | | | | | 2 | 0.07% |
| 31 | electric utilities central utilities | | | | | | | 2 | 0.07% |
| 32 | prepackaged software technology sec | | | | | | | 2 | 0.07% |
| 33 | see more sec form | | | | | | | 2 | 0.07% |
| 34 | a new price target | | | | | | | 2 | 0.07% |
| 35 | with a new price | | | | | | | 2 | 0.07% |
| 36 | financial results and provides | | | | | | | 2 | 0.07% |
| 37 | inc 0001162194 issuer 8924 | | | | | | | 2 | 0.07% |
| 38 | biotechnology laboratory analytical instruments | | | | | | | 2 | 0.07% |
| 39 | the company from key | | | | | | | 2 | 0.07% |
| 40 | bought 1718801 worth of | | | | | | | 2 | 0.07% |